Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 48 entries
Sorted by: Best Match Show Resources per page
Emergency treatment of headache.

Neurology

Rapoport AM, Silberstein SD.
PMID: 1557191
Neurology. 1992 Mar;42(3):43-4.

The first approach in the emergency treatment of headache is the use of abortive measures in an attempt to forestall progression of early signs and symptoms. Abortive measures include analgesics, antiemetics, and anxiolytics; nonsteroidal anti-inflammatory drugs; ergots, generally preceded...

Cite
Rapoport AM, Silberstein SD. Emergency treatment of headache. Neurology. 1992;42(3):43-4
Rapoport, A. M., & Silberstein, S. D. (1992). Emergency treatment of headache. Neurology, 42(3), 43-4.
Rapoport, A M, and Silberstein, S D. "Emergency treatment of headache." Neurology vol. 42,3 (1992): 43-4.
Rapoport AM, Silberstein SD. Emergency treatment of headache. Neurology. 1992 Mar;42(3):43-4. PMID: 1557191.
Copy Download .nbib Format: NLM
Cerebral Venous Thrombosis with Migraine-Like Headache and the Trigeminovascular System.

Case reports in neurological medicine

Nascimento FA, Sória MG, Rizelio V, Kowacs PA.
PMID: 26989532
Case Rep Neurol Med. 2016;2016:2059749. doi: 10.1155/2016/2059749. Epub 2016 Feb 17.

Cerebral venous thrombosis- (CVT-) associated headache is considered a secondary headache, commonly presenting as intracranial hypertension headache in association with seizures and/or neurological signs. However, it can occasionally mimic migraine. We report a patient presenting with a migraine-like, CVT-related...

Cite
Nascimento FA, Sória MG, Rizelio V, et al. Cerebral Venous Thrombosis with Migraine-Like Headache and the Trigeminovascular System. Case Rep Neurol Med. 2016;2016:2059749doi: 10.1155/2016/2059749.
Nascimento, F. A., Sória, M. G., Rizelio, V., & Kowacs, P. A. (2016). Cerebral Venous Thrombosis with Migraine-Like Headache and the Trigeminovascular System. Case reports in neurological medicine, 20162059749. https://doi.org/10.1155/2016/2059749
Nascimento, Fábio A, et al. "Cerebral Venous Thrombosis with Migraine-Like Headache and the Trigeminovascular System." Case reports in neurological medicine vol. 2016 (2016): 2059749. doi: https://doi.org/10.1155/2016/2059749
Nascimento FA, Sória MG, Rizelio V, Kowacs PA. Cerebral Venous Thrombosis with Migraine-Like Headache and the Trigeminovascular System. Case Rep Neurol Med. 2016;2016:2059749. doi: 10.1155/2016/2059749. Epub 2016 Feb 17. PMID: 26989532; PMCID: PMC4773529.
Copy Download .nbib Format: NLM
Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial.

CJEM

Innes GD, Macphail I, Dillon EC, Metcalfe C, Gao M.
PMID: 17659098
CJEM. 1999 Apr;1(1):26-33. doi: 10.1017/s1481803500006989.

OBJECTIVE: To determine whether the addition of intravenous dexamethasone to standard emergency department (ED) migraine therapy would decrease the incidence of severe recurrent headache 24 to 48 hours after initial treatment.METHODS: Patients aged 19 to 65 years whose headache...

Cite
Innes GD, Macphail I, Dillon EC, et al. Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial. CJEM. 1999;1(1):26-33doi: 10.1017/s1481803500006989.
Innes, G. D., Macphail, I., Dillon, E. C., Metcalfe, C., & Gao, M. (1999). Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial. CJEM, 1(1), 26-33. https://doi.org/10.1017/s1481803500006989
Innes, G D, et al. "Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial." CJEM vol. 1,1 (1999): 26-33. doi: https://doi.org/10.1017/s1481803500006989
Innes GD, Macphail I, Dillon EC, Metcalfe C, Gao M. Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial. CJEM. 1999 Apr;1(1):26-33. doi: 10.1017/s1481803500006989. PMID: 17659098.
Copy Download .nbib Format: NLM
Allodynia as a complication of migraine: background and management.

Current treatment options in neurology

Young WB.
PMID: 19094830
Curr Treat Options Neurol. 2009 Jan;11(1):3-9. doi: 10.1007/s11940-009-0001-0.

Allodynia is a normal part of the untreated migraine attack in most people with episodic migraine and is prevalent in chronic migraine. The extent to which allo-dynia contributes to the pain and disability of migraine attacks is unclear, as...

Cite
Young WB. Allodynia as a complication of migraine: background and management. Curr Treat Options Neurol. 2009;11(1):3-9doi: 10.1007/s11940-009-0001-0.
Young, W. B. (2009). Allodynia as a complication of migraine: background and management. Current treatment options in neurology, 11(1), 3-9. https://doi.org/10.1007/s11940-009-0001-0
Young, William B. "Allodynia as a complication of migraine: background and management." Current treatment options in neurology vol. 11,1 (2009): 3-9. doi: https://doi.org/10.1007/s11940-009-0001-0
Young WB. Allodynia as a complication of migraine: background and management. Curr Treat Options Neurol. 2009 Jan;11(1):3-9. doi: 10.1007/s11940-009-0001-0. PMID: 19094830.
Copy Download .nbib Format: NLM
An examination of certain factors which might, or do, affect the vascular response to oxytocin.

The Journal of physiology

Lloyd S, Pickford M.
PMID: 16992296
J Physiol. 1967 Dec;193(3):547-69. doi: 10.1113/jphysiol.1967.sp008378.

1. A number of different observations were made on anaesthetized rats and some dogs to try to discover why it is that oxytocin is a vasodilator in dioestrus and anoestrus, and develops constrictor properties in oestrus and following sympathectomy.2....

Cite
Lloyd S, Pickford M. An examination of certain factors which might, or do, affect the vascular response to oxytocin. J Physiol. 1967;193(3):547-69doi: 10.1113/jphysiol.1967.sp008378.
Lloyd, S., & Pickford, M. (1967). An examination of certain factors which might, or do, affect the vascular response to oxytocin. The Journal of physiology, 193(3), 547-69. https://doi.org/10.1113/jphysiol.1967.sp008378
Lloyd, S, and Pickford, M. "An examination of certain factors which might, or do, affect the vascular response to oxytocin." The Journal of physiology vol. 193,3 (1967): 547-69. doi: https://doi.org/10.1113/jphysiol.1967.sp008378
Lloyd S, Pickford M. An examination of certain factors which might, or do, affect the vascular response to oxytocin. J Physiol. 1967 Dec;193(3):547-69. doi: 10.1113/jphysiol.1967.sp008378. PMID: 16992296; PMCID: PMC1365513.
Copy Download .nbib Format: NLM
About the effect of atropine, 1-hyoscyamine, scopolamine, cocaine, choline, methylene blue, caffeine, histidine and dihydroergotamine on the rabbit's eye pressure.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde

SCHENK F.
PMID: 18134259
Ophthalmologica. 1949 Jul;118(1):42-65. doi: 10.1159/000300706.

No abstract available.

Cite
SCHENK F. Ueber die Wirkung von Atropin, 1-Hyoscyamin, Scopolamin, Cocain, Cholin, Methylenblau, Coffein, Histidin und Dihydroergotamin auf den Augendruck des Kaninchens. About the effect of atropine, 1-hyoscyamine, scopolamine, cocaine, choline, methylene blue, caffeine, histidine and dihydroergotamine on the rabbit's eye pressure. Ophthalmologica. 1949;118(1):42-65doi: 10.1159/000300706.
SCHENK, F. (1949). Ueber die Wirkung von Atropin, 1-Hyoscyamin, Scopolamin, Cocain, Cholin, Methylenblau, Coffein, Histidin und Dihydroergotamin auf den Augendruck des Kaninchens. About the effect of atropine, 1-hyoscyamine, scopolamine, cocaine, choline, methylene blue, caffeine, histidine and dihydroergotamine on the rabbit's eye pressure. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 118(1), 42-65. https://doi.org/10.1159/000300706
SCHENK, F. "Ueber die Wirkung von Atropin, 1-Hyoscyamin, Scopolamin, Cocain, Cholin, Methylenblau, Coffein, Histidin und Dihydroergotamin auf den Augendruck des Kaninchens." About the effect of atropine, 1-hyoscyamine, scopolamine, cocaine, choline, methylene blue, caffeine, histidine and dihydroergotamine on the rabbit's eye pressure. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde vol. 118,1 (1949): 42-65. doi: https://doi.org/10.1159/000300706
SCHENK F. Ueber die Wirkung von Atropin, 1-Hyoscyamin, Scopolamin, Cocain, Cholin, Methylenblau, Coffein, Histidin und Dihydroergotamin auf den Augendruck des Kaninchens. About the effect of atropine, 1-hyoscyamine, scopolamine, cocaine, choline, methylene blue, caffeine, histidine and dihydroergotamine on the rabbit's eye pressure. Ophthalmologica. 1949 Jul;118(1):42-65. doi: 10.1159/000300706. German. PMID: 18134259.
Copy Download .nbib Format: NLM
Uptake of 5-hydroxytryptamine by platelets.

British journal of pharmacology and chemotherapy

Stacey RS.
PMID: 19108152
Br J Pharmacol Chemother. 1961 Jun;16(3):284-95. doi: 10.1111/j.1476-5381.1961.tb01087.x.

Human blood platelets were incubated with 5-hydroxytryptamine and with tryptamine and the uptake of each amine measured. The uptake of tryptamine, unlike that of 5-hydroxytryptamine, was linearly related to the concentration of the amine in the surrounding fluid, was...

Cite
Stacey RS. Uptake of 5-hydroxytryptamine by platelets. Br J Pharmacol Chemother. 1961;16(3):284-95doi: 10.1111/j.1476-5381.1961.tb01087.x.
Stacey, R. S. (1961). Uptake of 5-hydroxytryptamine by platelets. British journal of pharmacology and chemotherapy, 16(3), 284-95. https://doi.org/10.1111/j.1476-5381.1961.tb01087.x
Stacey, R S. "Uptake of 5-hydroxytryptamine by platelets." British journal of pharmacology and chemotherapy vol. 16,3 (1961): 284-95. doi: https://doi.org/10.1111/j.1476-5381.1961.tb01087.x
Stacey RS. Uptake of 5-hydroxytryptamine by platelets. Br J Pharmacol Chemother. 1961 Jun;16(3):284-95. doi: 10.1111/j.1476-5381.1961.tb01087.x. PMID: 19108152; PMCID: PMC1482019.
Copy Download .nbib Format: NLM
Acute migraine therapy: new drugs and new approaches.

Current treatment options in neurology

Monteith TS, Goadsby PJ.
PMID: 21110235
Curr Treat Options Neurol. 2011 Feb;13(1):1-14. doi: 10.1007/s11940-010-0105-6.

OPINION STATEMENT: The conceptual shift of our understanding of migraine from a vascular disorder to a brain disorder has dramatically altered the approach to the development of new medicines in the field. Current pharmacologic treatments of acute migraine consist...

Cite
Monteith TS, Goadsby PJ. Acute migraine therapy: new drugs and new approaches. Curr Treat Options Neurol. 2011;13(1):1-14doi: 10.1007/s11940-010-0105-6.
Monteith, T. S., & Goadsby, P. J. (2011). Acute migraine therapy: new drugs and new approaches. Current treatment options in neurology, 13(1), 1-14. https://doi.org/10.1007/s11940-010-0105-6
Monteith, Teshamae S, and Goadsby, Peter J. "Acute migraine therapy: new drugs and new approaches." Current treatment options in neurology vol. 13,1 (2011): 1-14. doi: https://doi.org/10.1007/s11940-010-0105-6
Monteith TS, Goadsby PJ. Acute migraine therapy: new drugs and new approaches. Curr Treat Options Neurol. 2011 Feb;13(1):1-14. doi: 10.1007/s11940-010-0105-6. PMID: 21110235; PMCID: PMC3016076.
Copy Download .nbib Format: NLM
Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus.

Journal of neurosciences in rural practice

Mullaguri N, Hepburn M, Newey CR, Nattanmai PC.
PMID: 29725183
J Neurosci Rural Pract. 2018 Apr-Jun;9(2):272-275. doi: 10.4103/jnrp.jnrp_449_17.

Reversible cerebral vasoconstriction syndrome (RCVS) is a clinicoradiological syndrome that occurs due to dysfunction of cerebrovascular autoregulation. It is characterized by recurrent thunderclap headache from cerebral vasoconstriction which can cause ischemic infarction, spontaneous intraparenchymal and subarachnoid hemorrhage. This syndrome...

Cite
Mullaguri N, Hepburn M, Newey CR, et al. Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus. J Neurosci Rural Pract. 2018;9(2):272-275doi: 10.4103/jnrp.jnrp_449_17.
Mullaguri, N., Hepburn, M., Newey, C. R., & Nattanmai, P. C. (2018). Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus. Journal of neurosciences in rural practice, 9(2), 272-275. https://doi.org/10.4103/jnrp.jnrp_449_17
Mullaguri, Naresh, et al. "Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus." Journal of neurosciences in rural practice vol. 9,2 (2018): 272-275. doi: https://doi.org/10.4103/jnrp.jnrp_449_17
Mullaguri N, Hepburn M, Newey CR, Nattanmai PC. Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus. J Neurosci Rural Pract. 2018 Apr-Jun;9(2):272-275. doi: 10.4103/jnrp.jnrp_449_17. PMID: 29725183; PMCID: PMC5912038.
Copy Download .nbib Format: NLM
The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura.

Hippokratia

Miljković S, Smajlović D, Tirić Campara M, Jurina R, Duranović Vinković L, Janković SM, Begović B, Ćeranić M.
PMID: 31213753
Hippokratia. 2018 Jan-Mar;22(1):17-22.

BACKGROUND: Dihydroergotamine or ergotamine are the most effective preparations for aborting acute attacks of migraine without aura.OBJECTIVE: The aim of our study was to compare the efficacy and safety of ergotamine based five-component drug combination and sumatriptan in the...

Cite
Miljković S, Smajlović D, Tirić Campara M, et al. The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura. Hippokratia. 2018;22(1):17-22
Miljković, S., Smajlović, D., Tirić Campara, M., Jurina, R., Duranović Vinković, L., Janković, S. M., Begović, B., & Ćeranić, M. (2018). The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura. Hippokratia, 22(1), 17-22.
Miljković, S, et al. "The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura." Hippokratia vol. 22,1 (2018): 17-22.
Miljković S, Smajlović D, Tirić Campara M, Jurina R, Duranović Vinković L, Janković SM, Begović B, Ćeranić M. The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura. Hippokratia. 2018 Jan-Mar;22(1):17-22. PMID: 31213753; PMCID: PMC6528700.
Copy Download .nbib Format: NLM
Development and Evaluation of an Integrated Outpatient Infusion Care Model for the Treatment of Pediatric Headache.

Pediatric neurology

Shapiro HFJ, Sant J, Minster A, Antonelli RC.
PMID: 34959159
Pediatr Neurol. 2021 Dec 02;127:41-47. doi: 10.1016/j.pediatrneurol.2021.11.012. Epub 2021 Dec 02.

BACKGROUND: Care for pediatric patients with headache often occurs in high-cost settings such as emergency departments (EDs) and inpatient settings. Outpatient infusion centers have the potential to reduce care costs for pediatric headache management.METHODS: In this quality improvement study,...

Cite
Shapiro HFJ, Sant J, Minster A, et al. Development and Evaluation of an Integrated Outpatient Infusion Care Model for the Treatment of Pediatric Headache. Pediatr Neurol. 2021;127:41-47doi: 10.1016/j.pediatrneurol.2021.11.012.
Shapiro, H. F. J., Sant, J., Minster, A., & Antonelli, R. C. (2021). Development and Evaluation of an Integrated Outpatient Infusion Care Model for the Treatment of Pediatric Headache. Pediatric neurology, 12741-47. https://doi.org/10.1016/j.pediatrneurol.2021.11.012
Shapiro, Hannah F J, et al. "Development and Evaluation of an Integrated Outpatient Infusion Care Model for the Treatment of Pediatric Headache." Pediatric neurology vol. 127 (2021): 41-47. doi: https://doi.org/10.1016/j.pediatrneurol.2021.11.012
Shapiro HFJ, Sant J, Minster A, Antonelli RC. Development and Evaluation of an Integrated Outpatient Infusion Care Model for the Treatment of Pediatric Headache. Pediatr Neurol. 2021 Dec 02;127:41-47. doi: 10.1016/j.pediatrneurol.2021.11.012. Epub 2021 Dec 02. PMID: 34959159.
Copy Download .nbib Format: NLM
Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations.

Journal of pain research

Shafqat R, Flores-Montanez Y, Delbono V, Nahas SJ.
PMID: 32431533
J Pain Res. 2020 Apr 30;13:859-864. doi: 10.2147/JPR.S203650. eCollection 2020.

Dihydroergotamine (DHE) is an ergot alkaloid derivative of substances produced by rye fungus. Ergotamine was first used in the field of gynecology and obstetrics, then used for migraine treatment a few years later. DHE was developed as a derivative...

Cite
Shafqat R, Flores-Montanez Y, Delbono V, et al. Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations. J Pain Res. 2020;13:859-864doi: 10.2147/JPR.S203650.
Shafqat, R., Flores-Montanez, Y., Delbono, V., & Nahas, S. J. (2020). Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations. Journal of pain research, 13859-864. https://doi.org/10.2147/JPR.S203650
Shafqat, Rafia, et al. "Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations." Journal of pain research vol. 13 (2020): 859-864. doi: https://doi.org/10.2147/JPR.S203650
Shafqat R, Flores-Montanez Y, Delbono V, Nahas SJ. Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations. J Pain Res. 2020 Apr 30;13:859-864. doi: 10.2147/JPR.S203650. eCollection 2020. PMID: 32431533; PMCID: PMC7200221.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 48 entries